Ignite Creation Date:
2024-05-05 @ 11:29 PM
Last Modification Date:
2024-10-26 @ 10:35 AM
Study NCT ID:
NCT01347216
Status:
RECRUITING
Last Update Posted:
2024-02-20
First Post:
2011-05-03
Brief Title:
COMPERA COMPERA-KIDS
Sponsor:
Technische Universität Dresden
Organization:
Technische Universität Dresden
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Pulmonary Hypertension PH |
| Pulmonary Arterial Hypertension PAH |
Keywords:
| Name | View |
|---|---|
| Drug treatment | View |
| Treatment pathways | View |
| Clinical routine | View |
| Registry | View |
| Treatment outcomes | View |
| Endothelin receptor antagonist | View |
| Phosphodiesterase-V inhibitor | View |
| Prostanoid | View |
| Sildenafil | View |
| Bosentan | View |
| Macitentan | View |
| Sitaxentan | View |
| Ambrisentan | View |
| Imatinib | View |
| Epoprostenol | View |
| Treprostinil | View |
| Iloprost | View |
| Infusion pump | View |
| Riociguat | View |
| soluble guanylate cyclase stimulator | View |
| Quality of life | View |
| Patient-related outcomes | View |
| Economic model | View |
| Adverse event | View |
| Safety | View |
| Combination therapy | View |
| Internet | View |
| Europe | View |
| Eisenmenger | View |
| Adults | View |
| Children | View |
| Selexipag | View |
| Baltic states | View |
| Risk | View |